Treatment updates in Merkel cell carcinoma

2 Views
administrator
administrator
07/17/23

Dr Nghiem speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about the latest finding in the field of Merkel cell carcinoma. He highlights that there have been major developments in the settings of first-line treatment, treatment after chemotherapy and the neoadjuvant setting.

He goes on to discuss the importance and benefit of immune therapy over chemotherapy in this setting.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next